Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)
PHASE3
The objective of this trial is to evaluate the efficacy and safety of two d...
Status
Completed
Location
1220.47.0004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
PHASE3
The aim of this trial is to evaluate the efficacy and the safety of BI 2013...
Status
Completed
Location
1220.7.0091 Boehringer Ingelheim Investigational Site
A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
PHASE3
This is a study to evaluate the efficacy and safety of three experimental d...